(Q35084891)

6 August 2017

1 reference

title

Hepatitis C virus and arthritis (English)

1 reference

6 August 2017

1 reference

1 reference

Ignazio Olivieri

1

1 reference

PubMed ID

12635503

6 August 2017

Carlo Palazzi

series ordinal

2

1 reference

PubMed ID

12635503

6 August 2017

Angela Padula

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

Rheumatic Diseases Clinics of North America

6 August 2017

1 reference

6 August 2017

29

1 reference

6 August 2017

1

1 reference

6 August 2017

111-122

1 reference

Replication of hepatitis C virus

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

The molecular virology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C-associated arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

The spectrum of extrahepatic manifestations in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

A rheumatic syndrome with Laennec's cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

False-positive anti-HCV tests in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

True positive anti-HCV tests in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Development of Rheumatoid Arthritis after Chronic Hepatitis Caused by Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Polyarthritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Rheumatic manifestations of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Symmetric polyarthritis with livedo reticularis: a newly recognized manifestation of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Adult Still's disease associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Management of hepatitis C virus-related arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Has hepatitis C virus a specific tropism for the synovial membrane?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus and mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Anti-ENA antibodies in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Extrahepatic immunologic features of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Anti-inflammatory drugs and variceal bleeding: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Preventive care in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Selected drug complications and treatment conflicts in the presence of coexistent diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Chronic hepatitis C infection and psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Psoriasis induced by interferon-α

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Psoriasis with articular involvement induced by interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Exacerbation of psoriasis after treatment with alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Psoriasis and alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Psoriatic arthritis and alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Treatment of psoriasis and psoriatic arthritis with interferon gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

Treatment of psoriatic arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900097-2

7 January 2021

10.1016/S0889-857X(02)00097-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12635503